Top Takeaways:
- CAPHRA claims that the WHO tobacco treaty is influenced by donor-funded NGOs rather than governments.
- The analysis claims that harm-reduction policies and consumer voices are being sidelined.
- The group warns that ideological enforcement is encouraging illegal trade and eroding public confidence.
A new analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) criticizes the World Health Organization’s tobacco control treaty for being increasingly influenced by donor-funded advocacy groups instead of governments. It warns that this shift is damaging public health outcomes and harming the treaty’s credibility.
The report, titled “The FCTC Secretariat’s Deepening Legitimacy Problem,” claims that the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) has strayed from its original goal as a government-led, evidence-based policy organization and now functions, in practice, as a platform for non-governmental organizations funded by U.S. philanthropies.
According to the analysis, these organizations now play a key role in shaping policy language, setting enforcement priorities, and publicly pressuring countries that stray from strict prohibition-focused approaches. The report states that harm-reduction experts, consumer groups, and independent researchers are often excluded from policy discussions.
“The FCTC Secretariat allowing these NGOs to write the decisions to be actioned, then hold court and shame countries who refuse to abide by the scripted rules is in direct contradiction to the treaty itself,” said Nancy Loucas, executive coordinator of CAPHRA and co-author of the report. “This has nothing to do with actual health gains and everything to do with control.”
CAPHRA also argues that adult smokers and users of safer nicotine alternatives are marginalized in international policy debates and are portrayed as abstract public health risks rather than as stakeholders affected by regulatory decisions.
“The most significant failure is the exclusion and dehumanization of the very people the treaty is meant to protect,” said Clarisse Virgino, CAPHRA’s representative in the Philippines and co-author of the analysis. “Adults who smoke are denied participation in decisions directly affecting their lives and invalidates their lived experiences.”
The report highlights New Zealand as an example of policy outcomes being distorted by ideology. The country achieved a smoking rate of 6.8% — among the lowest worldwide — largely through the regulated expansion of vaping and alternative nicotine products, CAPHRA said. Despite this achievement, Bloomberg-funded advocacy groups awarded New Zealand a so-called “Dirty Ashtray Award” for straying from prohibition-aligned policy positions.
CAPHRA warned that ignoring consumer perspectives is leading to unintended consequences, such as limited access to lower-risk options, increased illegal trade, and declining public trust in health authorities. The group said these impacts are particularly severe in low- and middle-income countries where illegal markets already control the nicotine supply.
The organization called for structural reform of the FCTC process, urging governments to reclaim agenda-setting authority, expand transparent civil-society participation and strengthen independent scientific review free from single-donor funding influence. The report also calls on the FCTC Secretariat to disclose all external policy involvement and restore clear boundaries between advocacy groups and treaty governance.
“The suggestion that any country supporting harm reduction must be aligned with industry is unacceptable,” Virgino said. “Public health decisions should be based on evidence, not ideology.”
Loucas emphasized that ignoring these concerns could cause long-term harm to the credibility of both the FCTC and the WHO. “The WHO cannot maintain authority if global health governance favors private funding agendas over evidence and member state interests,” she said.
